ESC 365 - Novel anti-obesity drugs - a paradigm shift for disease prevention?

Open Access

Novel anti-obesity drugs - a paradigm shift for disease prevention?

Session: Novel weight loss strategies to reduce cardiovascular risk in obesity

Topic: Obesity

Speaker: Professor J. Wilding (Liverpool, GB)

Sponsored by Medscape Education Global

Event: ESC Congress 2023

Congress Presentation

About the speaker

Professor John Wilding

University of Liverpool, Liverpool (United Kingdom of Great Britain & Northern Ireland)

1 presentation

0 follower

4 more presentations in this session

Obesity - a chronic disease and origin of multiple cardiovascular morbidities

Speaker: Professor J. Deanfield (London, GB)

Delivering obesity care in cardiology practice

Speaker: Professor L. van Rossum (Rotterdam, NL)

Stepping up to the challenge of active obesity care

Speaker: Professor J. Deanfield (London, GB)

Q&A

Access the full session

Novel weight loss strategies to reduce cardiovascular risk in obesity

Speakers: Professor J. Wilding, Professor J. Deanfield, Professor L. van Rossum, Professor J. Deanfield

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by